1st Quarter - Report — THE NICKLES GROUP, LLC for GILEAD SCIENCES, INC. (2020)

Firm

THE NICKLES GROUP, LLC

Client

GILEAD SCIENCES, INC.

Income

$50,000

Expenses

—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues related to the reimbursement of CAR-T therapy; monitored issues related to S. 2543, Prescription Drug Pricing Reduction Act of 2019 and H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act.

Lobbyist	Covered position, as disclosed
STACEY HUGHES	—
MARY BETH SAVARY TAYLOR	—

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB)

Bills named: H.R. 3 (116th), S. 2543 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.